亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。
Identification of Arginine Deiminase Gene Therapy for Disordered Proteins
技術優勢
Decreases tau levels, Metabolizes arginine, Does not increase nitric oxide or polyamines
詳細技術說明
Our inventorΓÇÖs have successfully mammalianized, cloned, and expressed arginine deiminase (ADI) to deplete arginine without increasing either nitric oxide or polyamines. When overexpressed in the brain of tau transgenic mice, ADI significantly decreased tau pathology. Additionally, ADI reduced tau levels in cells that overexpress tau. This novel gene therapy by ADI may serve as a therapeutictarget in reducing aggregation prone proteins such as tau, thus leading to a promising new treatment for age-associated neurodegenerative diseases.
國家/地區
美國
欲了解更多信息，請點擊 這裡
